Data / Drug companies / Amoxicillin and clavulanate potassium
Amoxicillin and clavulanate potassium: 35 companies and 203 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Amoxicillin and clavulanate potassium is listed in the FDA National Drug Code Directory by 35 companies, with 203 products in commercial distribution. 189 of the products (93.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; powder, for suspension; tablet, and the newest product started marketing on September 21, 2026.
The request: Get every company that lists amoxicillin and clavulanate potassium in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 35
- Products
- 203
- Generic (ANDA) products
- 189 (93.1%)
- Application numbers
- 33
- Routes
- Oral
- Brand names
- Augmentin, Augmentin Es-600
- openFDA record search
- api.fda.gov
Companies that list amoxicillin and clavulanate potassium
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 31 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | September 19, 2022 |
| A-S Medication Solutions | 17 | powder, for suspension; tablet, film coated | Generic drugs (ANDA) | November 21, 2022 |
| Preferred Pharmaceuticals Inc. | 13 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | July 31, 2026 |
| Remedyrepack Inc. | 10 | tablet, film coated; tablet | Generic drugs (ANDA) | September 21, 2026 |
| Asclemed USA, Inc. | 9 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | May 1, 2020 |
| Proficient Rx LP | 9 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | January 20, 2012 |
| PD-Rx Pharmaceuticals, Inc. | 8 | tablet, film coated; tablet | Generic drugs (ANDA) | August 23, 2016 |
| Sportpharm LLC | 8 | tablet, film coated; tablet, multilayer, extended release | Generic drugs (ANDA) | August 12, 2019 |
| Bryant Ranch Prepack | 7 | tablet, film coated | Generic drugs (ANDA) | March 1, 2017 |
| Chartwell RX, LLC | 7 | powder, for suspension; tablet | Generic drugs (ANDA) | March 22, 2005 |
| Proficient Rx LP | 7 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | May 1, 2020 |
| Sandoz Inc | 7 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | April 21, 2010 |
| Aurobindo Pharma Limited | 6 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | January 20, 2012 |
| NorthStar Rx LLC | 6 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | January 20, 2012 |
| USAntibiotics, LLC | 6 | for suspension; tablet, coated | Authorized generics (NDA) | December 15, 2025 |
| Bryant Ranch Prepack | 5 | tablet, film coated | Generic drugs (ANDA) | March 1, 2017 |
| Devatis, Inc. | 5 | powder, for suspension; tablet, film coated | Generic drugs (ANDA) | November 1, 2024 |
| Teva Pharmaceuticals USA, Inc. | 5 | powder, for suspension; tablet, film coated | Generic drugs (ANDA) | January 13, 2005 |
| Hikma Pharmaceuticals USA Inc. | 4 | powder, for suspension; tablet | Generic drugs (ANDA) | August 23, 2016 |
| Proficient Rx LP | 4 | powder, for suspension; tablet, film coated | Generic drugs (ANDA) | November 21, 2022 |
| American Health Packaging | 3 | tablet, film coated | Generic drugs (ANDA) | July 26, 2024 |
| Micro Labs Limited | 3 | tablet, film coated | Generic drugs (ANDA) | March 1, 2017 |
| Advanced Rx of Tennessee, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | March 3, 2023 |
| Aurobindo Pharma Limited | 2 | powder, for suspension | Generic drugs (ANDA) | April 19, 2019 |
| Bryant Ranch Prepack | 2 | tablet, film coated | Generic drugs (ANDA) | January 20, 2012 |
| Coupler LLC | 2 | tablet, film coated | Generic drugs (ANDA) | May 7, 2026 |
| Hawaii Repack, Inc. | 2 | powder, for suspension | Generic drugs (ANDA) | December 20, 2011 |
| Medsource Pharmaceuticals | 2 | tablet, film coated | Generic drugs (ANDA) | March 1, 2017 |
| Northwind Health Company, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | October 17, 2024 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | October 31, 2002 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | October 31, 2002 |
| Redpharm Drug | 2 | for suspension; powder, for suspension | Authorized generics (NDA) | September 19, 2022 |
| Allegis Holdings, LLC | 1 | for suspension | New drug applications (NDA) | September 1, 2023 |
| Cipla USA Inc. | 1 | suspension | Generic drugs (ANDA) | October 28, 2024 |
| Direct_Rx | 1 | tablet, film coated | Generic drugs (ANDA) | October 7, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 112 | 55.2% |
| Powder, for suspension | 54 | 26.6% |
| Tablet | 13 | 6.4% |
| For suspension | 7 | 3.4% |
| Suspension | 7 | 3.4% |
| Tablet, coated | 5 | 2.5% |
| Tablet, multilayer, extended release | 2 | 1% |
| Tablet, chewable | 2 | 1% |
| Tablet, film coated, extended release | 1 | 0.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 189 | 93.1% |
| Authorized generics (NDA) | 11 | 5.4% |
| New drug applications (NDA) | 3 | 1.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Penicillin-class Antibacterial | 203 |
| beta Lactamase Inhibitor | 203 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.